Vaccinex Inc 's (VCNX) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Vaccinex Inc   (NONE: VCNX)
 



  Vaccinex Inc Outlook

On April 2 2024 the Vaccinex Inc provided following guidance

Vaccinex Inc. has released its financial results for 2023 and provided a comprehensive corporate update. The company anticipates unveiling the topline data from the randomized SIGNAL-AD study evaluating Pepinemab for Alzheimer's Disease in the third quarter of 2024. In order to support its research and development efforts, Vaccinex secured $17.9 million in new financing during the fourth quarter of 2023 and the first quarter of 2024.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.